The purpose of this study is to assess the prevention and treatment effect of transcutaneous acupoint electrical stimulation on hypotension after intraspinal anesthesia.
After being informed about the study and potential risks, all patients giving written informed consent will undergo the doctors' and researchers' examination to determine eligibility for study entry. At beginning of the study, patients who meet the eligibility requirements will be randomized in a open manner(participant and electroacupuncture executor)in a 1:1 ratio to TEAS group (10 minutes before intraspinal anesthesia, bilateral Neiguan points and Zusanli points are given dense wave transcutaneous acupoint electrical stimulation with the frequency of 10/50Hz. The intensity is based on the maximum tolerance of the participant, and the stimulation last until 30 minutes after subarachnoid administration) or Control group (Electrodes are connected at bilateral Neiguan points and Zusanli points 10 minutes before intraspinal anesthesia, but no transcutaneous acupoint electrical stimulation is given, the duration is the same as that of the TEAS group).
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
NONE
Enrollment
64
The corresponding transcutaneous acupoint electrical stimulation is given to different groups before spinal anesthesia, which last from 10 minutes before anesthesia to 30 minutes after subarachnoid administration.
First Affiliated Hospital of Xian Jiaotong University
Xi'an, Shaanxi, China
incidence of hypotension
the incidence of hypotension within 30 minutes after subarachnoid administration in TEAS group was significantly lower than that in Control group.
Time frame: within 30 minutes after subarachnoid administration
specific changes of hemodynamic indexes
compared with Control group, the changes of hemodynamic indexes in TEAS group were more stable.
Time frame: within 30 minutes after subarachnoid administration
usage of ephedrine
the usage of ephedrine within 30 minutes after subarachnoid administration in TEAS group was significantly less than that in Control group.
Time frame: within 30 minutes after subarachnoid administration
incidence of nausea and vomiting
the incidence of nausea and vomiting within 30 minutes after subarachnoid administration in TEAS group was significantly lower than that in Control group.
Time frame: within 30 minutes after subarachnoid administration
incidence of dizziness, chest tightness and dyspnea
the incidence of dizziness, chest tightness and dyspnea within 30 minutes after subarachnoid administration in TEAS group was significantly lower than that in Control group.
Time frame: within 30 minutes after subarachnoid administration
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.